1. Home
  2. AAPG vs ORIC Comparison

AAPG vs ORIC Comparison

Compare AAPG & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascentage Pharma Group International American Depository Shares

AAPG

Ascentage Pharma Group International American Depository Shares

N/A

Current Price

$13.05

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

N/A

Current Price

$7.71

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AAPG
ORIC
Founded
2009
2014
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2024
2020

Fundamental Metrics

Financial Performance
Metric
AAPG
ORIC
Price
$13.05
$7.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
16
Target Price
★ $44.50
$21.79
AVG Volume (30 Days)
5.4K
★ 1.9M
Earning Date
08-19-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 19.67
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$17.91
N/A
Revenue Next Year
$111.96
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.12
$7.23
52 Week High
$33.09
$14.68

Technical Indicators

Market Signals
Indicator
AAPG
ORIC
Relative Strength Index (RSI) 34.59 33.48
Support Level N/A $7.40
Resistance Level $16.28 $14.23
Average True Range (ATR) 0.44 0.66
MACD -0.17 -0.07
Stochastic Oscillator 0.00 7.98

Price Performance

Historical Comparison
AAPG
ORIC

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: